<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04343105</url>
  </required_header>
  <id_info>
    <org_study_id>pecto-intercostal plane block</org_study_id>
    <nct_id>NCT04343105</nct_id>
  </id_info>
  <brief_title>Pecto-intercostal Plane Block in On-pump Coronary Bypass Graft Surgery</brief_title>
  <official_title>The Effect of Ultrasound-guided Bilateral Single Shot Pecto -Intercostal Plane Block on Recovery After On-pump Coronary Bypass Graft Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fast track and ultrafast track cardiac anaesthesia appear to demonstrate improved outcomes
      without compromising patient safety. Their benefits include shorter intensive care unit
      stays, reduced duration of mechanical ventilation and lower health care costs. Regional
      anesthesia has played an important role in enhanced recovery pathways for other surgical
      services and allows for reduced systemic opioid use during intraoperative and postoperative
      care This study will be conducted to evaluate the effectiveness and safety of ultrasound
      guided bilateral single shot pecto - intercostal plane block on recovery after on pump CABG
      surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fast-track anesthesia (FTA) is a procedure that enables extubation in intensive care unit
      (ICU) within 6 h after surgery to facilitate the recovery of consciousness and autonomous
      breathing. It has been safely applied to cardiac surgery since the 1990s.

      FTA is feasible and safe and reduces the occurrence of ventilator induced complications,
      thereby decreasing ICU stay, resource use and cost.

      Ultra-fast tract anesthesia (UFTA) was developed after fast-track anesthesia to further
      optimize the use of medical resource. With UFTA, extubation is performed immediately or
      within 1 h after surgery in the operating room. The benefits of UFTA include lower incidence
      of postoperative complications, better hemodynamic performance, shorter ICU stay.

      Fast track and ultrafast track cardiac anaesthesia can be achieved by reduced opioid doses or
      opioid free with multimodal analgesia augmented with bilateral regional anaesthesia as pecto
      - intercostal plane block.

      Fast track and ultrafast track cardiac anaesthesia appear to demonstrate improved outcomes
      without compromising patient safety. Their benefits include shorter intensive care unit
      stays, reduced duration of mechanical ventilation and lower health care costs. Regional
      anesthesia has played an important role in enhanced recovery pathways for other surgical
      services and allows for reduced systemic opioid use during intraoperative and postoperative
      care.

      The anteromedial chest wall (i.e., the sternum and parasternal region) is innervated by the
      anterior branches of the intercostal nerves. These terminal anterior branches ascend in the
      parasternal region through the intercostal and pectoralis major muscles to innervate the
      superficial tissues. They can thus be targeted in one of two fascial planes: either deep into
      intercostal muscles and superficial to transversus thoracis muscles or superficial to the
      intercostal muscles and deep into pectoralis major muscle.

      The sensory innervation of the thorax is provided by the 2nd through 6th intercostal nerves.
      The intercostal nerves terminate in anterior cutaneous branches, which divide into medial and
      lateral branches, providing innervation to the anterior chest wall. A pecto - intercostal
      nerve block targets the anterior intercostal nerves just lateral to the sternum in the
      interfascial plane between pectoralis major muscle and external intercostal muscle.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 1, 2020</start_date>
  <completion_date type="Anticipated">May 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>extubation time</measure>
    <time_frame>up to 7 days postoperative</time_frame>
    <description>duration of mechanical ventilation from the end of anaesthesia till fulfillment weaning criteria and extubated</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative mean arterial blood pressure measurement</measure>
    <time_frame>within 24 hours postoperative</time_frame>
    <description>mean arterial blood pressure measurement in mm Hg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative heart rate measurement</measure>
    <time_frame>within 24 hours postoperative</time_frame>
    <description>heart rate measurement in beat/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU stay duration</measure>
    <time_frame>up to 7 days postoperative</time_frame>
    <description>from admission of ICU to discharge to ward</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain measurement by numerical rating scale</measure>
    <time_frame>within 24 hours postoperative</time_frame>
    <description>Numerical Rating Scale for pain that ranged from (0 = no pain) to (10 = intolerable pain). If score is &gt;3 will need analgesia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Enhanced Recovery After Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>sham group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>will receive sham bilateral ultrasounded guided single shot pecto-intercostal plane block between 3rd and 4th rib 2 cm lateral to sternal border for each side after induction of anaesthesia in supine position</description>
  </arm_group>
  <arm_group>
    <arm_group_label>real group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>will receive real bilateral ultrasounded guided single shot pecto-intercostal plane block between 3rd and 4th rib 2 cm lateral to sternal border for each side after induction of anaesthesia in supine position with 10 ml bupivacaine 0.5% + 10 ml lidocaine 2% in total volume 20 ml for each side.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pecto-intercostal plane block</intervention_name>
    <description>under ultrasound guidance, pecto-intercostal plane block will be performed between 3rd and 4th rib 2 cm lateral to sternal border in supine position at the interfascial plane between pectoralis major muscle and intercostal muscles</description>
    <arm_group_label>real group</arm_group_label>
    <arm_group_label>sham group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient aged more than 40 years old.

          -  scheduled for elective open-heart surgery including CABG with on pump cardiopulmonary
             bypass.

        Exclusion Criteria:

          -  Patients with severe pulmonary hypertension and / or heart failure.

          -  Emergency or combined cardiac surgery.

          -  Patients with preoperative use of intra-aortic balloon pump.

          -  Patients with poor ventricular function less than 45 %.

          -  Patients with preoperative uncontrolled arrhythmia.

          -  Patients with moderate to severe hepatic and / or renal dysfunction.

          -  Patients with anticipated difficult airway.

          -  Severe obstructive and / or restrictive pulmonary function test.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tarek Abdel Hay</name>
      <address>
        <city>Tanta</city>
        <state>El Gharbyia</state>
        <zip>31527</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 3, 2020</study_first_submitted>
  <study_first_submitted_qc>April 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2020</study_first_posted>
  <last_update_submitted>June 1, 2020</last_update_submitted>
  <last_update_submitted_qc>June 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>tarek abdel hay mostafa</investigator_full_name>
    <investigator_title>principle investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

